1. No category

This CECAM conference aims at discussing the state of the art of computational methods as effective
tools for drug discovery. Toward this end, we have integrated topics that are, and will remain, central
to the field, such as structure-based drug discovery and molecular modeling and simulations for drug
design, with the introduction of novel aspects that are nowadays among the hot topics in the field of
drug discovery, such as binding kinetics, and methods for target identification/validation.
S p e a k e r s
Prof. R. Abagyan (UC San Diego, USA)
Prof. P. Carloni (INM9/IAS-5, Jülich GmbH, DE)
Dr. G. Colombo (Istituto di Chimica, CNR, IT)
Dr. Z. Cournia (Academy of Athens, GR)
Dr. R. Lewis (Novartis, CH)
Dr. J. Mason (Heptares Therapeutics, UK)
Prof. O. Michielin (UniL, CH)
Prof. A. Mulholland (Bristol University, UK)
Prof. G. Cruciani (University of Perugia, IT)
Dr. A. Pan (DE Shaw Research, USA)
Dr. M.D. Cummings (Janssen, USA)
Prof. M. Parrinello (ETH Zurich, CH)
Dr. E. Duffy (Melinta Therapeutics, USA)
Prof. W. L. Jorgensen (Yale University, USA)
Prof. G. Klebe (Philipps-Universität Marburg, DE)
Prof. R. Levy (Temple University, USA)
Prof. U. Roethlisberger (EPFL, CH)
Prof. L. Scapozza (Université de Genève, CH)
Dr. W. Sherman (Schrodinger Inc., USA)
Prof. R. Walker (UC San Diego, USA)
O r g a n i z i n g
Prof. Andrea Cavalli
University of Bologna and IIT, Italy
Prof. Kenneth M. Merz Jr.
Michigan State University, USA
C o m m i t t e e
Prof. Matteo Dal Peraro
EPF Lausanne, Switzerland
Dr. Marco De Vivo
Istituto Italiano di Tecnologia, Italy
h t t p : / / s b d d 2 0 1 5 . e p f l . c h